BindingDB logo
myBDB logout

BDBM312472 2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-4,5,6,7-tetrahydro-benzo[b]thiophen-2-ylcarbamoyl]-4,4-dimethyl-cyclopent-1-enecarboxylic acid::US9604977, Example 218

SMILES: CC1(C)CC(C(O)=O)=C(C1)C(=O)Nc1sc2CCCCc2c1-c1nc(no1)C1CC1

InChI Key: InChIKey=CNUOYFHYSTWXNQ-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 312472   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Fatty acid-binding protein 5 (FABP5)


(Homo sapiens (Human))
BDBM312472
PNG
(2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-4,5,6,7...)
Show SMILES CC1(C)CC(C(O)=O)=C(C1)C(=O)Nc1sc2CCCCc2c1-c1nc(no1)C1CC1
Show InChI InChI=1S/C22H25N3O4S/c1-22(2)9-13(14(10-22)21(27)28)18(26)24-20-16(12-5-3-4-6-15(12)30-20)19-23-17(25-29-19)11-7-8-11/h11H,3-10H2,1-2H3,(H,24,26)(H,27,28)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 19n/an/an/an/an/an/a



Hoffman-La Roche Inc.

US Patent


Assay Description
Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...


US Patent US9604977 (2017)

More data for this
Ligand-Target Pair
Fatty acid-binding protein 4 (FABP4)


(Homo sapiens (Human))
BDBM312472
PNG
(2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-4,5,6,7...)
Show SMILES CC1(C)CC(C(O)=O)=C(C1)C(=O)Nc1sc2CCCCc2c1-c1nc(no1)C1CC1
Show InChI InChI=1S/C22H25N3O4S/c1-22(2)9-13(14(10-22)21(27)28)18(26)24-20-16(12-5-3-4-6-15(12)30-20)19-23-17(25-29-19)11-7-8-11/h11H,3-10H2,1-2H3,(H,24,26)(H,27,28)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 13n/an/an/an/an/an/a



Hoffman-La Roche Inc.

US Patent


Assay Description
Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...


US Patent US9604977 (2017)

More data for this
Ligand-Target Pair